Literature DB >> 9305986

Role of carbohydrate structures in the binding of beta1-latency-associated peptide to ligands.

Y Yang1, J D Dignam, L E Gentry.   

Abstract

Transforming growth factor beta1 (TGF-beta1) is a potent growth differentiation and morphogenesis factor. The amino-terminal 248 amino acid pro region of TGF-beta1, the beta1-latency-associated peptide (beta1-LAP), is noncovalently associated with TGF-beta1 in an inactive complex. Previous studies suggested that deglycosylated beta1-LAP can not form this latent complex with TGF-beta1. To study the role of the carbohydrate structures of beta1-LAP in its biological functions, we expressed simian beta1-LAP in Escherichia coli with a 10 histidine residue tag on the N-terminus. This polypeptide was solubilized from inclusion bodies with 6 M guanidine hydrochloride and purified by metal chelate affinity chromatography. Purified beta1-LAP was refolded to its dimeric form using a chaotrope-mediated folding procedure. The dimeric beta1-LAP forms 90 kDa complexes with TGF-beta1, TGF-beta2, and TGF-beta3, and reverses the inhibitory activity of TGF-beta1 on Mv1Lu cells. Solid phase binding assays demonstrate that refolded beta1-LAP binds to heparin and thrombospondin 1. FET cell adhesion promoted by refolded beta1-LAP was blocked by an RGD peptide. Purified beta1-LAP produced in Chinese hamster ovary cells, deglycosylated with N-glycosidase F, forms a 80-90 kDa complex with mature TGF-beta1. The carbohydrate structures of beta1-LAP are not required for binding to ligands or for its biological activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9305986     DOI: 10.1021/bi9710479

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

Review 1.  Review of the activation of TGF-beta in immunity.

Authors:  Andrew W Taylor
Journal:  J Leukoc Biol       Date:  2008-09-25       Impact factor: 4.962

Review 2.  The latent transforming growth factor beta binding protein (LTBP) family.

Authors:  R Oklü; R Hesketh
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

Review 3.  Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins.

Authors:  Ian B Robertson; Daniel B Rifkin
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-06-01       Impact factor: 10.005

4.  Enhanced antimycobacterial response to recombinant Mycobacterium bovis BCG expressing latency-associated peptide.

Authors:  B G Marshall; A Wangoo; P O'Gaora; H T Cook; R J Shaw; D B Young
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

5.  Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36.

Authors:  T Yehualaeshet; R O'Connor; J Green-Johnson; S Mai; R Silverstein; J E Murphy-Ullrich; N Khalil
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

6.  Interactions between growth factors and integrins: latent forms of transforming growth factor-beta are ligands for the integrin alphavbeta1.

Authors:  J S Munger; J G Harpel; F G Giancotti; D B Rifkin
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

Review 7.  Unchaining the beast; insights from structural and evolutionary studies on TGFβ secretion, sequestration, and activation.

Authors:  Ian B Robertson; Daniel B Rifkin
Journal:  Cytokine Growth Factor Rev       Date:  2013-07-12       Impact factor: 7.638

Review 8.  Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer.

Authors:  Jing Zhang; Peter Ten Dijke; Manfred Wuhrer; Tao Zhang
Journal:  Protein Cell       Date:  2020-06-25       Impact factor: 14.870

9.  TGFbeta1 signaling via alphaVbeta6 integrin.

Authors:  Martin P Kracklauer; Christian Schmidt; Guido M Sclabas
Journal:  Mol Cancer       Date:  2003-08-07       Impact factor: 27.401

10.  Prokaryotic expression, purification and evaluation of anti-cardiac fibrosis activity of recombinant TGF-β latency associated peptide.

Authors:  Xudong Song; Yufei Qiu; Jiayi Shi; Luxin Li; Xiaohuan Yuan; Dan Wu; Yanhui Chu
Journal:  PeerJ       Date:  2022-01-19       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.